Association Between Dose Dialysis by Kt and Mortality

NephroCare

Status: Completed

Conditions: Hemodialysis Patients; End Stage Renal Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT01932853

QM-RR-02

Details and patient eligibility

About

The aim of this study is to assess whether patients receiving current recommendations of an adequate dialysis dose by Kt adjusted for body surface area improved survival at 24 months compared to those who do not get it, as well as assess whether patients receiving a dose greater obtain more benefit.

Enrollment: 6,129 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• > 18 years old
• > six months on hemodialysis
• Receiving 3 sessions of dialysis per week
• Having 5 or more valid measures of Kt during the month

Exclusion criteria

• active chronic inflammatory diseases
• Liver cirrhosis
• Neoplasms
• Chronic immunosuppression or use of anti-inflammatory

Trial design

6,129 participants in 1 patient group

Hemodialysis patients

Description:

Patients > 18y hemodialysis for at least 6 months at any center of Spain Fresenius Medical Care (FMC) meeting the inclusion criteria.